High Cardiovascular Risk trials recruiting in Alabama

Fewer than 3 recruiting trials found.

All High Cardiovascular Risk trials nationally

Cities in Alabama

Recruiting trials in Alabama

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham, Fairhope, Foley, Huntsville